Skip to main content
    C

    Chemomab Therapeutics Ltd DRC (CMMB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.64
    +0.02 (+1.23%)

    Market Cap: $12.31M

    Last updated: Nov 17, 2026 at 4:04 PM ET

    Chemomab Therapeutics Ltd DRC (CMMB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Chemomab Therapeutics Ltd DRC (CMMB) has a market cap of $12.31M and an enterprise value of $6.32M. Its share count is up 38.13% from a year earlier. It holds $6.00M more cash than debt, 48.71% of its market cap.

    Total Valuation

    Enterprise value is 48.71% below the market cap, as cash exceeds debt.

    Market Cap$12.31M
    Enterprise Value$6.32M
    Latest price (Nov 17, 2026)$1.64

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.31% in the quarter ended Jun 30, 2026 and grew 569.03% a year over 2 years.

    Shares Outstanding8.00M
    Shares Change (YoY)+38.13%
    Shares Change (QoQ)+0.31%
    Share Count Growth (2Y CAGR)+569.03%

    Price Statistics

    The stock is down 38.35% over 52 weeks and trades 1.86% above its 50-day average.

    Beta (1Y)1.35
    52-Week Change-38.35%
    1-Month Change+40.17%
    3-Month Change-21.53%
    6-Month Change+5.81%
    5-Year Change-97.11%
    Total Return (1Y)-38.35%
    Total Return (3Y CAGR)-10.36%
    Total Return (5Y CAGR)-46.20%
    Return vs SPY (1Y)-51.49%
    Max Drawdown (1Y)-64.66%
    Max Drawdown (3Y)-89.84%
    Sharpe Ratio (1Y)-0.53
    Correlation with SPY (1Y)0.19
    50-Day Average$1.61
    200-Day Average$1.74
    52-Week Range$0.92 to $2.99
    RSI (14 Days)68.1
    Average Volume (20 Days)68.72K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.41x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.41x
    Quick Ratio6.41x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -87.53% and return on assets is -74.25% over the last 12 months.

    Return on Equity (ROE)-87.53%
    Return on Assets (ROA)-74.25%
    ROIC (5Y Average)-78.56%

    Scores

    CMMB has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$7.96M
    Pretax Income-$7.60M
    Net Income-$7.60M
    Reported EPS (TTM)-$2.81

    Trailing 12 months through Jun 30, 2026.

    Balance Sheet

    Shareholder equity funds 84.77% of the $10.24M in total assets.

    Cash and Equivalents$6.00M
    Total Debt$0
    Net Cash$6.00M
    Working Capital$8.40M
    Shareholder Equity$8.68M
    Total Assets$10.24M
    Total Liabilities$1.55M

    Balance sheet as of Jun 30, 2026.

    Cash Flow

    Capital Expenditures$3.03K
    FCF Per Share-$3.44

    Trailing 12 months through Jun 30, 2026.

    Stock Splits

    The last split was a 1-for-4 reverse split on Aug 26, 2025.

    Last Split DateAug 26, 2025
    Split TypeReverse split
    Split Ratio1:4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CMMB

    What is CMMB's market cap?

    Chemomab Therapeutics Ltd DRC has a market cap of $12.31M. Its enterprise value, which adds debt and subtracts cash, is $6.32M.

    How many shares of CMMB are outstanding?

    Chemomab Therapeutics Ltd DRC has 8.00M shares outstanding. The count is up 38.13% from a year earlier.

    Does CMMB pay a dividend?

    No. Chemomab Therapeutics Ltd DRC does not pay a dividend.

    How much debt does CMMB have?

    Chemomab Therapeutics Ltd DRC has $0 of total debt and $6.00M of cash and equivalents, a net cash position of $6.00M.